Effects of insulin-like growth factor (IGF) binding protein-3 (IGFBP-3) on endometrial cancer (HHUA) cell apoptosis and EGF stimulated cell proliferation in vitro

被引:16
|
作者
Mochizuki, Tomoko [1 ]
Sakai, Keiji [1 ]
Iwashita, Mitsutoshi [1 ]
机构
[1] Kyorin Univ, Sch Med, Dept Obstet & Gynecol, Mitaka, Tokyo 1818611, Japan
关键词
IGFBP-3; EGF; apoptosis; endometrial cancer;
D O I
10.1016/j.ghir.2006.05.002
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Objective: IGFBP-3 has been demonstrated to stimulate or inhibit cell proliferation independently of its ability to bind IGF and a specific IGFBP-3 receptor has been proposed. EGF has been implicated in the cancer development and carcinogenesis. Only limited data are available on the crosstalk between IGFBP-3 signaling and EGF induced cell survival and signal transduction. The current studies were undertaken to characterize IGFBP-3 binding to endometrial cancer cells (HHUA) and determine its biological effects, as well as whether IGFBP-3 exposure alters the cell proliferation stimulated by EGF. Methods: Cell proliferation and apoptosis were analyzed by ELISA using specific antibodies. The interaction between HHUA cell and IGFBP-3 was analyzed using a biosensor. The phosphorylation abundance of specific proteins and their phosphorylation in response to EGF and IGFBP-3 was analyzed by immunoprecipitation followed by immunoblotting. Results: Biosensor analysis showed that IGFBP-3 could bind to HHUA cell surface. IGFBP-3 inhibited BrdU uptake, potentiated ssDNA production and induced p53 in HHUA cells. Although EGF stimulated HHUA cell proliferation and Akt phosphorylation, IGFBP-3 inhibited cell proliferation and Akt phosphorylation that had been stimulated by EGF. However, EGF receptor phosphorylation and expression were not reduced by IGFBP-3. Since HHUA cells lack 1GF receptors and do not show biological response to IGF these results suggest that IGFBP-3 can bind to HHUA cells, inhibit cell proliferation and induce apoptosis independently of its ability to bind to IGFs possibly by binding to an IGFBP-3 receptor. Conclusions: Taken together these findings demonstrate that IGFBP-3 binds to HHUA cell surface, and inhibits cell division induced by EGF, possibly by modulating the EGF-mediated signal transduction system. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:202 / 210
页数:9
相关论文
共 50 条
  • [21] Clinical significance of serum insulin-like growth factor-1 (IGF-1) and insulin-like growth factor binding protein-3 (IGFBP-3) in patients with breast cancer
    Tas, Faruk
    Karabulut, Senem
    Bilgin, Elif
    Tastekin, Didem
    Duranyildiz, Derya
    TUMOR BIOLOGY, 2014, 35 (09) : 9303 - 9309
  • [22] Insulin-like growth factor binding-protein-3 (IGFBP-3)
    Ranke, Michael B.
    BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2015, 29 (05) : 701 - 711
  • [23] Epidemiology and biology of insulin-like growth factor binding protein-3 (IGFBP-3) as an anti-cancer molecule
    Ali, O
    Cohen, P
    Lee, KW
    HORMONE AND METABOLIC RESEARCH, 2003, 35 (11-12) : 726 - 733
  • [24] Reference values for insulin-like growth factor-binding protein-3 (IGFBP-3) and the ratio of insulin-like growth factor-I to IGFBP-3 throughout childhood and adolescence
    Löfqvist, C
    Andersson, E
    Gelander, L
    Rosberg, S
    Hulthen, L
    Blum, WF
    Wikland, KA
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (03): : 1420 - 1427
  • [25] Relationship of insulin-like growth factor (IGF) binding protein-3 (IGFBP-3) gene polymorphism with the susceptibility to development of prostate cancer and influence on serum levels of IGF-I, and IGFBP-3
    Safarinejad, Mohammad Reza
    Shafiei, Nayyer
    Safarinejad, Shiva
    GROWTH HORMONE & IGF RESEARCH, 2011, 21 (03) : 146 - 154
  • [26] CLINICAL SIGNIFICANCE OF SERUM INSULIN-LIKE GROWTH FACTOR-1 (IGF-1) AND INSULIN-LIKE GROWTH BINDING PROTEIN-3 (IGFBP-3) IN PATIENTS WITH GASTRIC CANCER
    Bademler, Suleyman
    Sari, Murat
    Ucuncu, Muhammet Zubeyr
    Serilmez, Murat
    Karabulut, Senem
    ACTA MEDICA MEDITERRANEA, 2018, 34 (06): : 2055 - 2060
  • [27] Characterization of insulin-like growth factor binding protein-3 (IGFBP-3) binding to human breast cancer cells: Kinetics of IGFBP-3 binding and identification of receptor binding domain on the IGFBP-3 molecule
    Yamanaka, Y
    Fowlkes, JL
    Wilson, EM
    Rosenfeld, RG
    Oh, Y
    ENDOCRINOLOGY, 1999, 140 (03) : 1319 - 1328
  • [28] Enhanced insulin-like growth factor-I (IGF-I) cell association at reduced pH is dependent on IGF binding protein-3 (IGFBP-3) interaction
    Forsten-Williams, Kimberly
    Cassino, Theresa R.
    Delo, Laura J.
    Bellis, Abigail D.
    Robinson, Anne S.
    Ryan, Thomas E.
    JOURNAL OF CELLULAR PHYSIOLOGY, 2007, 210 (02) : 298 - 308
  • [29] Oestrogen regulation of insulin-like growth factor binding protein-3 (IGFBP-3) and expression of IGFBP-3 messenger RNA in the ovine endometrium
    Peterson, AJ
    Ledgard, AM
    Hodgkinson, SC
    REPRODUCTION FERTILITY AND DEVELOPMENT, 1998, 10 (03) : 241 - 247
  • [30] Insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) is closely associated with the chondrocyte nucleus in human articular cartilage
    Hunziker, E. B.
    Kapfinger, E.
    Martin, J.
    Buckwalter, J.
    Morales, T. I.
    OSTEOARTHRITIS AND CARTILAGE, 2008, 16 (02) : 185 - 194